The Study
Ezetimibe plus statin combination versus double-dose statin in patients with dyslipidemia and atherosclerotic cardiovascular disease risk: a comprehensive systematic review and meta-analysis of 47 randomized controlled trials
This study combines results from 47 earlier experiments where patients were randomly given different cholesterol medicines. It gives good clues about which treatment lowers bad cholesterol more, but doesn’t prove one is better at preventing heart attacks or saving lives.
Analysis score
Maximum 100 for a systematic review with meta-analysis.
Where the score came from
Doctors wanted to know if adding a second cholesterol drug (ezetimibe) to a statin works better than just using a higher dose of the statin alone.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 539 / 100
Quality score
The highest quality evidence. These studies systematically search, appraise, and synthesize results from multiple individual studies, providing the most reliable summary of current knowledge.
Key takeaways
Summary
Based on the study abstract and findings.
- 1The combo helps reach cholesterol goals better, but doesn’t clearly protect the heart more than just increasing the statin dose.
- 2The combo lowered bad cholesterol more than doubling the statin.
- 3But it didn’t prevent more heart attacks or deaths.
- 4Serious side effects were slightly more common with the combo, but still very rare.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Baylor University Medical Center Proceedings
Year
2025
Authors
A. Mahmoud, Hazem Mohamed Salamah, H. Rezq, Yazan Al-Mohtasib, Ali Ashraf Salah Ahmed, M. R. Abdelraouf, A. Amin, A. A. Ibrahim, Yasmine Adel Mohammed, O. Abdelwahab, M. Albarakat, S. Elshenawy, Husam Abu Suilik, B. Abdelazeem
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.